An Efficient, Commercially Viable, and Safe Process for Preparation of Losartan Potassium, an Angiotensin II Receptor Antagonist-Reference-Cited by-同舟云学术

An Efficient, Commercially Viable, and Safe Process for Preparation of Losartan Potassium, an Angiotensin II Receptor Antagonist

Published:2012-11-01 Issue:12 Volume:16 Page:2025-2030
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Madasu Suri Babu¹²,Vekariya N. A.¹,Koteswaramma Ch¹,Islam Aminul¹,Sanasi Paul Douglas²,Korupolu Raghu Babu²

Affiliation:

1. Chemical Research and Development, Aurobindo Pharma Ltd., Survey Nos.71 and 72, Indrakaran (V), Sangareddy (M), Medak District 502329, Andhra Pradesh, India

2. Engineering Chemistry Department, AU College of Engineering, Andhra University, Visakhapatnam-530003, Andhra Pradesh, India

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/op300179u

Reference24 articles.

1. Sealy, J. E.; Laraugh, J. H.InHypertension: Pathaophysiology, Diagnosis and Management;Laraugh, J. H., Brenner, B. M., Eds.Raven:New York, 1990; p1287.

2. The renin-angiotensin system

3. Marsden, P. A.; Brnner, B. M.; Ballermann, B. J.InHypertension: Pathaophysiology, Diagnosis and Management;Laraugh, J. H.; Brenner, B. M., Eds.Raven:New York, 1990; p1247.

4. Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

5. A new class of angiotensin-converting enzyme inhibitors

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Degradation Profiles for Various Sartans under Solvent-Free Mechanochemical Conditions;Analytical Chemistry;2024-08-02

2. Targeted and untargeted screening for impurities in losartan tablets marketed in Germany by means of liquid chromatography/high resolution mass spectrometry;Journal of Pharmaceutical and Biomedical Analysis;2024-08

3. Mutagenic Azido Impurities in Drug Substances: A Perspective;Therapeutic Innovation & Regulatory Science;2024-07-01

4. Application of advanced high resolution mass spectrometric techniques for the analysis of losartan potassium regarding known and unknown impurities;Journal of Pharmaceutical and Biomedical Analysis;2024-03

5. The quality of drugs and drug products – Always guaranteed?;Journal of Pharmaceutical and Biomedical Analysis;2024-02